Helicobacter pylori treatment: New perspectives using current experience
- 1 March 2017
- journal article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 8, 123-130
Abstract
No abstract availableKeywords
This publication has 137 references indexed in Scilit:
- The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot StudyHelicobacter, 2012
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- Efficacy of Sitafloxacin-Based Rescue Therapy for Helicobacter pylori after Failures of First- and Second-Line TherapiesAntimicrobial Agents and Chemotherapy, 2012
- Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of IranJournal of Microbiology, 2011
- Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori InfectionHelicobacter, 2011
- 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trialThe Lancet, 2011
- Helicobacter pylori treatment in the era of increasing antibiotic resistanceGut, 2010
- Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication RateHelicobacter, 2009
- Helicobacter pyloriDetection and Antimicrobial Susceptibility TestingClinical Microbiology Reviews, 2007
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006